The strong impact of CMTM1_v17 in promoting tumor cell proliferation and lead to partial resistance to TNF-α-induced apoptosis likely via activation of NF-κB signaling pathway has been validated in breast cancer [11]. Here, NFKB1 is linked to breast cancer.